Attenua

AirNexis Therapeutics

This company develops inhaled small molecule medicines to treat chronic obstructive pulmonary disease for patients with respiratory conditions.

Afferent

This clinical-stage biopharmaceutical company develops small molecule drugs targeting P2X3 receptors to treat patients with chronic cough and other neurogenic disorders.

Attgeno

This company develops nitric oxide-donating drugs to treat patients with acute pulmonary hypertension and other conditions requiring targeted organ delivery.

Altesa BioSciences

This company develops antiviral medicines for patients with chronic lung diseases such as COPD and asthma to prevent respiratory infections and illness flare-ups.

Areteia Therapeutics

The company develops an oral medication for patients with eosinophilic asthma to reduce inflammation and manage their condition.

Avalyn Pharma

The company develops inhaled medicines to treat patients with rare respiratory diseases, including pulmonary fibrosis and other interstitial lung diseases.

AirNexis

This clinical-stage biotechnology company develops inhaled therapies for patients with chronic obstructive pulmonary disease and other respiratory conditions.

Activaero

The company develops controlled breathing systems and smart nebulisers to deliver inhaled drugs for patients with severe respiratory diseases.